886763-13-9 Usage
Uses
Used in Pharmaceutical Industry:
2-BROMO-5-(TRIFLUOROMETHOXY)BENZYL BROMIDE is used as a reagent for the synthesis of pharmaceutical compounds, leveraging its strong reactivity to introduce the benzyl bromide group into target molecules. This contributes to the development of new drugs with specific therapeutic properties.
Used in Agrochemical Industry:
In the agrochemical sector, 2-BROMO-5-(TRIFLUOROMETHOXY)BENZYL BROMIDE is employed as a reagent in the synthesis of agrochemicals, where its ability to introduce the benzyl bromide group is crucial for creating compounds with pesticidal or herbicidal activity.
Used as an Intermediate in Organic Synthesis:
2-BROMO-5-(TRIFLUOROMETHOXY)BENZYL BROMIDE is utilized as an intermediate in the production of other organic compounds, facilitating the creation of a diverse range of chemical entities for various applications, including but not limited to specialty chemicals and materials science.
Check Digit Verification of cas no
The CAS Registry Mumber 886763-13-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,6,7,6 and 3 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 886763-13:
(8*8)+(7*8)+(6*6)+(5*7)+(4*6)+(3*3)+(2*1)+(1*3)=229
229 % 10 = 9
So 886763-13-9 is a valid CAS Registry Number.
886763-13-9Relevant academic research and scientific papers
STEREORETENTIVE CROSS-COUPLING OF BORONIC ACIDS
-
Paragraph 0112; 0204-0206, (2018/11/21)
The present disclosure provides tri-orthoalkylphenyl phosphine catalysts that are tuned electrically and sterically. Method of using the catalyst for cross-coupling of unactivated secondary boronic acids with near-perfect levels of site- and stereoretention are also provided.
AUTOTAXIN INHIBITORS COMPRISING A HETEROAROMATIC RING-BENZYL-AMIDE-CYCLE CORE
-
Page/Page column 314, (2015/02/02)
The present invention relates to novel compounds that are autotaxin inhibitors, processes for their preparation, pharmaceutical compositions and medicaments containing them and to their use in diseases and disorders mediated by autotaxin.
